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Although the automatic synthesis of molecules has been established, each reaction 
class uses bespoke hardware. This means that the connection of multi-step syntheses 
in a single machine to run many different protocols and reactions is not possible, as 
manual intervention is required. Here we show how the Chemputer synthesis robot 
can be programmed to perform many different reactions, including solid-phase 
peptide synthesis, iterative cross-coupling and accessing reactive, unstable diazirines 
in a single, unified system with high yields and purity. Developing universal and 
modular hardware that can be automated using one software system makes a wide 
variety of batch chemistry accessible. This is shown by our system, which performed 
around 8,500 operations while reusing only 22 distinct steps in 10 unique modules, 
with the code able to access 17 different reactions. We also demonstrate a complex 
convergent robotic synthesis of a peptide reacted with a diazirine—a process 
requiring 12 synthetic steps. 
 
The synthesis of organic small molecules is still largely performed by hand in the 
laboratory, a paradigm that has barely changed in decades, despite predictions of 
imminent change1,2. The issue is that organic synthesis is not only labour intensive but 
also highly specialized, requiring years of training. Given these characteristics of 
organic synthesis, the automation of small-molecule synthesis has the potential to 
improve reproducibility and accessibility. However, the lack of a universal approach 
means that current technologies are highly specialized and focus on specific niches, 
for example, for the automated synthesis of oligopeptides3, oligonucleotides4, 
oligosaccharides5 and, recently, with MIDA boronate building blocks6. All these 
approaches are based on the successive iteration of a small number of robust 
reactions; hence, they are not generally programmable nor are the unit operations 
reusable. Such systems are ideal for process intensification but require extensive 
method development and specific hardware7. These limitations have been partly 
addressed by the development of reconfigurable flow systems addressing a wider 
range of chemistries8,9. What is needed is a paradigm that not only captures the 
expertise and numerous hours spent discovering and optimizing batch reactions but 
also is amenable to the development of an overarching ontology that allows 
universality. 
Previously, the concept of the Chemputer, a programmable batch synthesis robot, was 
designed and developed to demonstrate the proof of principle for a general approach 
to the synthesis of any organic molecule, whereby a range of different molecules 
could be automatically synthesized on the same hardware10. However, the ability to 
converge existing disparate automation strategies is a significant challenge. A good 
example highlighting these limitations is the classic iterative formation of peptides, 
one of the first classes of reactions to be automated3,11. While highly tuned for the 
iterative steps, not all systems can handle the final deprotection and cleavage12 of the 
peptide from the solid-phase resin13,14 and, to the best of our knowledge, no system 
can perform the final precipitation of the product without manual intervention. 
Moreover, once produced in the peptide synthesizer, the product compounds cannot 
then be used in the same type of robot for any further automatic procedure beyond 
peptide coupling chemistry except for some limited additional bespoke post-synthetic 
modifications, and these are not generally programmable across different systems. 
What is needed is a universal approach that could unify such processes within one 
architecture, allowing the system to be programmable and modular and hence capable 
of the synthesis of nearly any molecule that could be made manually. Here, we show 
how it is possible to develop the Chemputer paradigm such that a single system is 
capable of the automatic execution of iterative cross-coupling (ICC) MIDA-boronate-
based Suzuki–Miyaura coupling reactions, solid-phase peptide synthesis (SPPS), 
cleavage from the resin, deprotection and isolation, and the synthesis of succinimidyl 
4,4′-azipentanoate (NHS-diazirine)—a photoreactive crosslinker with important 
applications in biology15 and materials science16 (Fig. 1). During this unification 
process, we also designed a range of new ‘chemical hardware’ modules and showed 
how these could be versioned and improved to create new iterations of the hardware. 
We found that this approach is critical to enhancing the reliability and functionality of 
the hardware whilst ensuring interoperability of the software. 
 
 
Figure 1: The aim of this work is the convergence of distinct automated synthesis approaches into a single 
programmable and unified technology. Commercial solutions exist for well-established technologies such as 
iterative peptide synthesis3, and custom robotic platforms were built for more specialized tasks such as 
iterative Suzuki–Miyaura cross-coupling reactions using MIDA boronate building blocks6. The synthesis of 
sensitive molecules such as diazirines15 was not previously automated owing to the operational challenges. 
Merging and extending the capabilities of existing platforms facilitates the automation of these different 
classes of small-molecule syntheses using the same hardware and software. Abbreviations: D, deprotection; 




The path towards a universal synthesis machine was paved by previous efforts to 
automate specific reaction classes, such as SPPS and ICC chemistry based on the 
Suzuki–Miyaura reaction. As the first step, we aimed to merge these efforts and 
automate them in a uniform way, using standard synthetic chemistry unit operations 
(for example, separation, filtration, evaporation, heating, cooling, stirring and so on). 
To do this, a series of automated base steps were required, which can be built up to 
the overall unit operation. For example, the ‘Evaporation’ unit operation consists of 
the following base steps: 
x A Move base step to move a liquid to an evaporator 
x A StartEvaporation base step to begin the evaporation 
x A Wait base step to wait for a given time 
x A StopEvaporation base step to stop the evaporator 
x A final Move base step to move the concentrated liquid to the target 
destination 
A key principle of our strategy was to mimic the manual organic synthesis workflow 
closely—something that has not been achieved before. The advantage of this 
approach is that existing batch procedures, which have been developed for manual 
syntheses, can be easily automated using the platform, and this defines a universal, 
programmable system architecture or ontology—critical for the digitization of 
chemical synthesis and currently lacking (Fig. 2). To achieve this, it was crucial to 
define a set of unit operations that can be described by a universal and unequivocal 
chemical language, which in turn is interpretable and executable by standard 
automated ‘chemical hardware’. The ideal ‘chemical hardware’ (that is, glassware, 
plasticware, actuators) has been designed so that it can be constantly versioned, 
allowing continuous evolution to maximize the universality of the Chemputer whilst 
ensuring backward compatibility. 
 
 
Figure 2: Mapping of a specific synthesis to a generalized automated laboratory hardware assembly. Top 
line: every synthesis consists of a finite number of different unit operations, which can be further abstracted 
into executable code. Bottom line: every laboratory hardware assembly consists of a set of standard 
modules. For the purpose of automation, these are interconnected, and the connectivity is described as a 
graph. 
A key feature of the architecture was to design the hardware modules so that they are 
logically and physically self-contained units. These modules are connected via the 
liquid-handling backbone, which in turn connects all the modules to each other as 
well as additional resources including reagents and solvents. The connectivity of the 
modules with the liquid-handling backbone is described as a graph. The graph file is 
used by the software to locate all available hardware resources. This highly modular 
approach makes the architecture readily extendible, and it is easy to make changes in 
one module without affecting the rest of the system. The modularity of the 
architecture in terms of the hardware and software allows a formal ontological 
description that is universal for all chemical syntheses, which is a key feature of the 
Chemputer. Moreover, the system becomes programmable and facilitates the 
continuous expansion of the capabilities of the architecture in principle until full 
universality is achieved. 
The first step towards the automation of the three target syntheses—ICC, NHS-
diazirine synthesis and SPPS—was to analyse the underlying unit operations as 
described in Fig. 3. Once these unit operations were identified, it was possible to 
develop a universal software ‘wrapper’ to link each unit operation to a corresponding 
hardware module on the basis of the provided graph file. These software ‘wrappers’ 
were developed as Python libraries, which can be used to translate the syntheses 
operations into simple Python commands that are executable on the physical platform. 
By moving towards the use of Python in the Chemputer (in contrast to the custom 
syntax previously reported), we have provided increased flexibility, usability and 
openness for the platform’s software ‘wrapper’. 
 
 
Figure 3: Automated synthesespresented in this work. a, Iterative MIDA boronate cross-coupling 
chemistry. b, NHS-diazirine synthesis. c, SPPS followed by derivatization with NHS-diazirine. The 




The first reaction class we developed for automation in our system is based on the 
ICC sequence, which consists of three high-level steps: deprotection, coupling and 
purification6. While the deprotection could be routinely performed using the standard 
hardware, the Suzuki–Miyaura cross-coupling reaction required a new deoxygenation 
unit operation as strict inert-gas and moisture-free conditions were required. Further, 
the ICC sequence required solutions and solvents to be dried and filtered at various 
stages. Moreover, the key ‘catch-and-release’ purification step, requiring the product 
to be dry-loaded onto a silica column, needed to be implemented in our architecture. 
The diazirine synthesis was able to utilize standard modules already developed for the 
platform; however, preliminary experiments showed that improvements in the 
handling and storage of sensitive chemicals were needed owing to low yields arising 
from the decomposition of reagents left for a prolonged period in the laboratory. In 
manual synthesis, such solutions would typically be made on demand by the chemist 
immediately before proceeding. Finally, we have enabled the Chemputer to perform 
solid-phase peptide synthesis. Although the underlying chemistry of the peptide 
synthesis is simple and robust, the challenge is to perform each synthetic step with 
high conversion and purity. To achieve this, it is essential to avoid cross-
contamination of reagents and solvents during the synthesis. Further, the agitation of 
the heterogenous mixture of the solid-phase resin and the liquid reagent solutions 
needed to be fine-tuned so that mixing is effective but does not damage the resin. 
Emulation of the highly specialized automation procedure used for the dedicated ICC 
system in our general platform required a new suite of unit operations. First, to allow 
for the strict moisture- and oxygen-free conditions required, these unit operations 
were combined into a programmable gas-vacuum manifold (PM) (Supplementary 
Section 4.9.2). The manifold consists of two rows of solenoid valves allowing 
switching between vacuum and a high- or low-pressure line of inert gas. In addition to 
the six switchable gas/vacuum ports, the PM provides nine passive inert-gas lines, 
which can be used to keep reagents under a protective atmosphere. In addition, the 
ICC reactions require solutions and solvents to be dried, filtered and loaded onto a 
solid silica support at various stages in the procedure. To fulfil all these requirements, 
a cartridge carousel was developed (Supplementary Section 4.15). The carousel 
accommodates up to six cartridges that were filled with either silica (for the catch-
and-release step), Celite (for filtrations), molecular sieves or magnesium sulphate (for 
drying solvents), and this forms one of the ten modules built for the system (Fig. 4). 
 
 
Figure 4: Summary of the available hardware modules. Each module is capable of a series of unit 
operations. These are represented as icons next to the modules. The figure also indicates how the modules 
are connected to the liquid-handling backbone, inert-gas supply, vacuum, solvent waste, fraction flasks and 
programmable manifold (Auto-SCHLENK). 
The NHS-diazirine also required a moisture-free environment; moreover, it posed a 
formidable challenge as temperature- and light-sensitive reagents were required in 
this synthesis. Thus, we developed a reagent module (Supplementary Section 4.10) 
that allowed chilling, stirring and maintaining an inert atmosphere. In addition, solids 
could be kept in the flask until required, whereupon they could be dissolved by 
addition of the appropriate solvent to the flask. Thus, the reagent module ensured that 
sensitive chemicals could be stored at low temperatures and dissolved directly before 
they were used in the synthesis. This new module was an important factor that 
substantially enhanced the conversion of the diaziridine formation step, as it allowed 
for the preparation of the hydroxylamine-O-sulfonic acid (HOSA) solution at 5 °C 
during the run17. 
A crucial part of the hardware library is the liquid–liquid extraction module. Critical 
to the operation of this module is its ability to detect the phase boundary formed 
between two immiscible liquid phases using a conductivity sensor. To make this 
sensor as general as possible and applicable to a wide range of solvent systems, a 
switchable system with two conductivity sensing modes was developed 
(Supplementary Section 4.13). The diazirine synthesis presented here, given the 
highly conductive organic phases, was used to help us improve the sensor design. 
Overall, the sensitivity was increased by more than an order of magnitude—the 
signal-to-noise ratio of the sensor was improved from around 5 to 60 in a typical use 
case. 
For the NHS-diazirine synthesis, a column chromatography module was also required 
to purify the final product (Supplementary Section 4.16). This module built on the 
structure of the cartridge carousel described above with only a single cartridge packed 
with the solid phase for the chromatography. The efflux of the cartridge is attached to 
a valve that acts as a distributor in the fraction collector. The valve directs the eluting 
solvent from the column either to the solvent waste or to one of the five collection 
flasks on the basis of predefined elution volumes. Finally, to achieve high yields in 
solid-phase peptide synthesis on the platform, extra cleaning routines and priming 
steps were added to the executable code to prevent cross-contamination of reagents 
(Supplementary Section 6.3). In addition, it was found that the typical three-necked 
flask used in all previous syntheses on the Chemputer was not suitable for solid-phase 
peptide synthesis. A suitable reactor was designed (Supplementary Section 4.11.2) 
with a filter frit to capture the solid-phase resin, and a fast-responding heating element 
that allowed for rapid heating cycles was required for efficient iterative synthetic 
steps. Gentle mixing of the system to avoid damage to the resin could be achieved in 
two ways: with an overhead stirrer or via the purging of gas through the reaction 
mixture. The final product of the NHS-diazirine synthesis was ultimately coupled to 
the peptide product from the SPPS. Thus, two different modular builds of our 
platform were shown to work towards the same final product in a convergent 
synthesis. The successful implementation of these three syntheses and their associated 
unit operations on the platform illustrates the convergence of the hardware and 
software used to perform automated organic chemistry in a single system. Once all 
the required modules were built, the precise configurations of the Chemputer were 
implemented (Fig. 5). 
 
 
Figure 5: Implementation and topology of the synthesis platform. a, Physical instance of the Chemputer 
used for the synthesis of NHS-diazirine. The discrete modules are highlighted in different colours and 
labelled. b, Representation of the same instance in graph format; the modules are highlighted according to 
the colour code used in a. 
The target for the ICC sequence was chosen to allow for a direct comparison with the 
specialized platform developed previously6. In the first step, the reagent and solvent 
were added to the separator module to deprotect the MIDA boronate 1. A liquid–
liquid extraction was then performed, followed by filtration and evaporation of the 
organic solvent in the rotary evaporator. The free boronic acid 2 was redissolved and 
deoxygenated by purging with argon. The deoxygenated boronic acid solution was 
slowly added to the reactor vessel, which was precharged with the catalyst, base and 
bromoaryl coupling partner. The final product 3 was obtained after liquid–liquid 
extraction, filtration, evaporation of the organic solvent and purification via the catch-
and-release protocol in a yield comparable to the specialist platform (Table 1). 
 
Table 1: Results for the three syntheses 
 
Compound Overall yield Reference yield Modules Synthetic steps Base steps Runtime (h) 
3 52% (0.33 g) 61%a 8 2 347 32 
7 21% (4.2 g) 27%b 6 3 931 70 
10a 10% (21 mg) 18%c 7 12d 2,661 112 
10b 48% (102 mg) – 2 8 1,314 15 
10c 50% (112 mg) 70%e 2 8 1,411 22 
1. aReference yield taken from ref. 6. 
2. bManual synthesis according to an equivalent protocol (Supplementary Section 6.2.3). 
3. cThe peptide was synthesized on a commercial peptide synthesizer, followed by manual derivatization with NHS-diazirine, cleavage from the 
resin, deprotection and purification (Supplementary Section 6.3.4). 
4. d12 steps in the overall convergent synthesis. 
5. eThe peptide was synthesized on a commercial peptide synthesizer, followed by manual cleavage from the resin, deprotection and purification 
(Supplementary Section 6.3.2). 
 
The NHS-diazirine 7 was selected owing to the high value of the final product and the 
operational challenges the synthesis poses, which are mainly due to the sensitivity of 
the final product and some of the reagents17. Moreover, there was no robust and 
reproducible procedure available in the literature. The imine was formed in the first 
step and transformed to the diaziridine 5 in situ by adding the corresponding reagents 
in the appropriate sequence while maintaining low temperature. After removing solid 
residues by filtration, the solvent was evaporated in the rotary evaporator. The 
diaziridine in 5 was oxidized to the diazirine, followed by liquid–liquid extraction, 
drying of the organic solvent phase and concentration to yield 62% of the 4-
diazirinepentanoic acid intermediate 6. The carboxylic acid in 6 was transformed into 
an activated ester, which required temperature control and exclusion of humidity. The 
final product was purified by column chromatography without manual intervention to 
give NHS-diazirine 7 in 21% yield (Table 1). Manual execution of the same synthesis 
protocol gave the product in comparable yield. 
The solid-phase peptide synthesis involved a repetitive cycle of adding reagents and 
removing them after the reaction by filtration, followed by a washing step and a 
drying step. The fully assembled peptide 9 must be cleaved from the resin and the 
side chains must be deprotected. In the Fmoc-SPPS, this final deprotection step is 
usually performed with a cocktail of concentrated trifluoroacetic acid (TFA) and 
scavenger reagents, which must be freshly prepared each time before use. The peptide 
product is then obtained as a solution in the TFA cocktail. To isolate the pure peptide 
from that mixture, the material is precipitated with diethyl ether at low temperatures 
and isolated by filtration. To ensure quantitative transfer of the final product from the 
filter, the peptide was redissolved in acetonitrile–water solvent mixture and then 
moved to a tared storage vial, purified by preparative HPLC and lyophilized as 
required (preparative HPLC and lyophilization were performed manually). The 
Chemputer SPPS gave the target materials 10a–10c in good yield and purity. The 
synthesis of 10a involved a light-sensitive and high-value NHS-diazirine 7 building 
block, which was prepared previously by another modular build of the Chemputer as 
described above. The target material was obtained in 10% overall yield and 95% 
purity in a total of nine synthetic steps (involving >2,600 base steps). This result was 
equivalent to the yield and purity obtained with a highly specialized SPPS system. It 
should be noted that this commercial system was not able to perform cleavage, 
deprotection and precipitation; hence, these steps had to be performed manually. 
The syntheses in Table 1 were run >15 times altogether (while improving the 
synthesis code), demonstrating the reliability of the hardware. Combined with the 
previous publication10, the Chemputer has now been demonstrated to successfully 
execute 17 different synthetic protocols with a total of 8,500 unit operations. To 
achieve this breadth of chemistry, only 10 different modules and 22 distinct steps 
were needed, highlighting how a single function can be reused in many different 




This work shows that the modular approach can unify different classes of automated 
molecule syntheses with a single platform architecture. This is illustrated by the 
successful preparation of three target molecules representing a range of different 
compound classes (Table 1). Only minor modifications to the actual hardware 
instantiation of the system were required to accommodate the diverse chemistry 
needed to access these molecules. It was merely a question of adding the appropriate 
modules to the spinal liquid-handling backbone of each instance. In fact, if enough 
space is available, a single hardware instance of the platform that contains all the 
modules required in the three syntheses can be built. It was further demonstrated how 
two instances of the Chemputer can work in tandem to deliver a high-value final 
product. The first instance produces the activated ester of the diazirine-containing 
molecule 7, which was then used by the second instance in the peptide synthesis. 
These types of products are key tools in biochemistry and medicinal chemistry, and 
are usually very expensive. The catalogue price of NHS-diazirine from Sigma-Aldrich 
is £221 per 50 mg as of 12:00 on 18 August 2020. A typical automated peptide 
synthesizer costs around £50k (based on several quotes). By contrast, the price for a 
standard Chemputer setup is £20k and the value of the NHS-diazirine synthesized per 
run is £15k (based on the Sigma-Aldrich price). In fact, the NHS-diazirine 
product 7 is so expensive that after two repetitions of the synthesis by the system, the 
market value of the material produced exceeds the cost of the Chemputer hardware. 
Current work is focused on expanding our module library to add support for low 
temperature (−78 °C), solid additions, photochemistry and electrochemistry. We 
believe that continued efforts towards expanding the Chemputer approach, hardware 
and software will result in the merging of distinct technologies into a universal, open-
standard synthesis platform that will increase collaboration and reproducibility and 
accelerate innovation. Moreover, such a platform could not only facilitate 
autonomous discovery workflows that have access to a diverse set of small molecules 






The Chempiler software suite consists of three Python modules: Chempiler, 
SerialLabware and ChemputerAPI. These modules are written entirely in Python 3.6. 
The full source code and documentation are available as supplementary files in 
\Software\Chemputer_Python_Modules and on GitHub 
(github.com/croningp/ChemputerConvergence). SerialLabware provides a Python 
library that allows us to control typical commercially available laboratory hardware 
such as hotplates or rotary evaporators (an implementation for several different brands 
for each type of device has been written). The main task of ChemputerAPI is to 
communicate with the custom-made pumps and valves of the Chemputer. Finally, 
Chempiler brings the functionality of the different devices together. It provides high-
level logic to perform concerted tasks using multiple devices such as moving liquids 
through the liquid-handling backbone or performing a phase separation. Chempiler 
reads in a graph file that describes the topology of the physical setup. A web app 
called Chemputer Graph has been developed to conveniently generate the required 
graph files. 
 
Chemputer architecture and hardware modules 
 
Most organic chemistry syntheses can be carried out using a limited and relatively 
small number of unit operations such as moving a reagent from source (for example, 
reagent flask) to destination (for example, reactor), stirring a mixture, active 
temperature control (for example, of the reaction vessel) and evaporation (for 
example, of a volatile solvent). Once all the unit operations required in a given 
synthesis were implemented by the hardware modules, the process could be executed. 
A given hardware module may have been able to perform several unit operations (for 
example, the separator could stir and detect the phase change of a biphasic mixture, 
the heating plate could control the temperature and stir). Most importantly, the unit 
operations were implemented in a general way in the hardware modules so that they 
could be reused many times in different contexts—for example, during one multi-step 
synthesis or between different syntheses. 
The different modules from the Chemputer module library could be combined freely 
to build a functional Chemputer hardware assembly. Material transport between 
different modules was performed by the liquid-handling backbone—a series of pumps 
and valves that were connected in a linear fashion (Supplementary Section 4.8). To 
achieve broad chemical resistance, the parts that came into contact with reactive 
chemicals were required to be manufactured from polyether ether ketone (PEEK) or 
polytetrafluoroethylene (PTFE). Most hardware modules were controlled and, where 
possible, also powered over Ethernet (PoE). As most standard laboratory hardware 
(hotplate, overhead stirrer, rotary evaporator, recirculating chiller) have a serial port 
but not an Ethernet connector, a serial-to-Ethernet converter was designed 
(Supplementary Section 4.17). It consisted of a commercial PoE splitter and a serial-
to-Ethernet converter board. Thus, every Chemputer hardware assembly constituted 
its own network with a PoE-capable switch (Supplementary Section 4.3) (the few 
third-party devices that had neither a serial nor an Ethernet port were connected 
directly via USB to the computer that ran the Chemputer software). The pumps and 
valves were custom-made using a stepper motor as an actuator and Hall sensors for 
positioning (Supplementary Sections 4.4–4.7). Two options to control vacuum and 
gas supply were developed. The first option was based on a Chemputer valve as used 
in the liquid-handling backbone (Supplementary Section 4.9.1) and provided one 
switchable vacuum/inert gas line. As a more general solution, a pneumatic manifold 
was designed (Supplementary Section 4.9.2), which provided six lines that could be 
switched between vacuum and either of two different pressures of inert gas or two 
different types of gas (for example, argon and air). The pneumatic manifold consisted 
of two rows of six 12 V solenoid valves. These were operated by an Arduino board 
with a custom-made shield. The shield allowed us to control and power the pneumatic 
manifold over Ethernet. Reagents were either charged in the storage flasks 
(Supplementary Section 4.10) as solutions or provided as solids, which were then 
dissolved on the fly during the synthesis. The advanced reagent bottle setup 
(Supplementary Section 4.10.2) consisted of a standard reagent bottle (Supplementary 
Section 4.10.1), a magnetic stirrer and a cooling jacket. The cooling jacket was 
connected to a recirculating chiller (Supplementary Section 4.12.2). The standard 
Chemputer reactor (Supplementary Section 4.11.1) consisted of a multi-neck round 
bottom flask on a stirrer hotplate and was connected to the liquid-handling backbone 
as well as to the inert gas supply. An inline filter was attached to the end of the 
feeding tube in cases where suspensions were formed during the reaction. The SPPS 
reactor (Supplementary Section 4.11.2) consisted of a filter frit (maximum volume: 
approximately 20 ml), a 60 W heating mat and a temperature sensor. A PID feedback 
loop implemented on Arduino controlled the power output of the heating mat to 
maintain the target temperature. The inlet of the filter frit was connected to the inert 
gas supply (to keep the reaction mixture under inert atmosphere if necessary) and the 
liquid-handling backbone (to add fresh reagents). The outlet of the filter frit was 
connected to a Chemputer valve that switched between vacuum, inert gas (for 
agitation of the reaction mixture via gas bubbling) or the liquid-handling backbone (to 
remove waste reagents, and eventually, the cleaved and deprotected peptide product). 
Further, an overhead stirrer was installed to allow for mechanical agitation. The 
jacketed filter (maximum volume: approximately 200 ml) was a filter frit with a 
heating jacket that was connected to a recirculating chiller (Supplementary 
Section 4.12). Similar to the SPPS reactor, the inlet of the jacketed filter was 
connected to (1) the liquid-handling backbone to add reagents and (2) to the inert gas 
supply to establish an inert atmosphere. The outlet of the filter was connected to a 
Chemputer valve that switched between inert gas, vacuum and the liquid-handling 
backbone. The content of the jacketed filter was agitated with an overhead stirrer. The 
separator consisted of a pear-shaped flask with an outlet at the bottom 
(Supplementary Section 4.13). This outlet was connected to the flow tube of the 
conductivity sensor. The conductivity sensor circuitry was, in essence, a voltage 
divider. The flow tube consisted of two isolated steel tubes and constituted one leg of 
the voltage divider. The other leg of the voltage divider consisted of a capacitor for 
noise filtering and a circuit that switched between two different reference resistances. 
The change in the output voltage of this voltage divider was indicative of a phase 
change (organic vs aqueous). An overhead stirrer was used to mix the biphasic 
mixture in the pear-shaped flask. Two different models of rotary evaporators were 
integrated into the Chemputer architecture: a BUCHI Rotavapor R-300 and an IKA 
RV10 (Supplementary Section 4.14). The rotary evaporator was connected to the 
liquid-handling backbone at two points. One tube reached the bottom of the 
evaporation flask to add the solution to be evaporated and to remove the concentrated 
product. A second connection was made to the outlet of the collection flask at the 
bottom of the condenser to remove the distilled solvent. The cartridge carousel 
(Supplementary Section 4.15) consisted of a Chemputer valve that was connected to 
the liquid-handling backbone and could switch between the inlet of six different 
cartridges. The outlets of these cartridges were combined via a six-way check valve 
into one line again, which was connected back to the liquid-handling backbone. The 
chromatography module (Supplementary Section 5.16) was an extension of the 
cartridge carousel. The solvent was pushed through the chromatography column by 
the pumps of the liquid-handling backbone. The six-way check valve was replaced 
with a second Chemputer valve. A third Chemputer valve was connected to the outlet 
of the chromatography column and switched between different fractions. Product 
fractions were hard-coded on the basis of the eluted volume. To conveniently arrange 
the Chemputer hardware in a fume hood, a shelving system that could be readily 
adapted to the dimensions of the available fume hood was designed (Supplementary 
Section 4.2). 
 
Automated Suzuki–Miyaura ICC 
 
The separator module was manually charged with 6-methyl-2-(m-tolyl)-1,3,6,2-
dioxazaborocane-4,8-dione 1 (1.96 g, 7.92 mmol, 3.0 equiv.) and the reactor module 
was charged with 2-(4-bromophenyl)-6-methyl-1,3,6,2-dioxazaborocane-4,8-dione 
(823 mg, 2.64 mmol, 1.0 equiv.), second-generation XPhos Buchwald precatalyst 
(104 mg, 0.132 mmol, 0.05 equiv.) and K3PO4 (5.04 g, 23.8 mmol, 9.0 equiv.). 
The automatic procedure started with the dissolution of the MIDA building block 1 in 
THF (100 ml) and aqueous NaOH (24 ml, 1 M, added at 2 ml min−1). The mixture was 
stirred for 40 min. After stirring, potassium phosphate buffer (24 ml, 0.5 M, pH = 6.0) 
was added, followed by diethyl ether (30 ml). The phases were separated and the 
organic layer was washed with brine (24 ml). The organic layer was passed through a 
drying cartridge and concentrated in the rotary evaporator. The free boronic 
acid 2 was dissolved in THF (20 ml) and transferred to a holding flask. This solution 
was then deoxygenated. Next, THF (28 ml) was added to the reactor and the resulting 
suspension was deoxygenated and heated to 55 °C. The solution of the free boronic 
acid 2 was slowly added to the reactor over 4 h. The holding flask was rinsed with 
THF (10 ml), which was subsequently added to the reactor. The reaction mixture was 
stirred at 55 °C for 8 h. The reaction mixture was prefiltered using an in-line filter, 
passed through a filtration cartridge filled with Celite and concentrated in the rotary 
evaporator. The crude product 3 was dissolved in THF (26 ml). The resulting solution 
was loaded onto a silica column in nine portions of approximately 3 ml each. After 
each portion was loaded, the column was dried under vacuum for 30 min. The column 
was then washed with diethyl ether (150 ml). Then, the product was eluted with THF 
(150 ml). The THF solution was transferred to the rotary evaporator and concentrated 
to dryness to give the pure product 3 as an off-white solid (445 mg, 52%). The full 
details can be found in Supplementary Section 6.1. 
 
Automated diazirine synthesis 
 
The jacketed filter was manually charged with anhydrous MgSO4 (2.0 g). 
Hydroxylamine-O-sulfonic acid (HOSA) (11.5 g), a solution of ammonia in methanol 
and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDCI) (11.5 g) were placed in 
advanced reagent bottles, capable of stirring and temperature control, and kept under 
argon at 5 °C. The following operations were automatically performed. Step 1: 
ammonia in methanol (80 ml, 7 M) was added to a jacketed filter followed by a 
solution of 4-oxopentanoic acid 4 in methanol (9.3 ml, 8.83 M). The mixture was 
cooled to −10 °C and stirred for 3 h. Then, a fresh solution of HOSA in methanol 
(60 ml) was prepared and added slowly to the reaction mixture over 30 min. When the 
addition was complete, the reaction was warmed up to 20 °C and stirred for 15 h. The 
reaction mixture was filtered and concentrated in vacuo at ambient temperature 
(below 27 °C) to give ammonium 3-(3-methyldiaziridin-3-yl)propanoate 5. Step 2: a 
reaction vessel was charged with aqueous KOH (15 ml, 9 M) and cooled to 0 °C. The 
crude product 5 in the rotary evaporator flask was dissolved in aqueous KOH (45 ml, 
0.1 M) and transferred to the reaction vessel. A solution of iodine in diethyl ether 
(13.9 g of iodine in 80 ml of diethyl ether) was added slowly over 30 min. When the 
addition was complete, the reaction was stirred at 0 °C for 1.5 h. The reaction was 
quenched by the addition of an aqueous solution of sodium sulphite (15 ml, 15% 
w/w). The phases were separated. The aqueous phase was acidified by the addition of 
aqueous HCl (32 ml, 3 M) and extracted with diethyl ether (4 × 40 ml). The organic 
phases were dried by passing them through a cartridge packed with MgSO4 and sand 
(3:1 w/w) and concentrated in vacuo to give pure 3-(3-methyl-3H-diazirin-3-
yl)propanoic acid 6. Step 3: the product 6 in the rotary evaporator was dissolved in 
dichloromethane (20 ml) and transferred to a new reaction vessel. The solution was 
cooled to 0 °C. A solution of EDCI (11.5 g, 60.0 mmol) in dichloromethane (120 ml) 
was freshly prepared and added to the reaction mixture over 10 min at 0 °C. Then, a 
solution of N-hydroxysuccinimide in acetonitrile (5.66 g, 15 ml) was added and the 
reaction was stirred for 15 h at 20 °C. The reaction mixture was concentrated in 
vacuo. A silica flash chromatography column (150 g) was equilibrated with 
dichloromethane (550 ml). The crude material was redissolved in dichloromethane 
(60 ml), loaded onto the column and eluted with dichloromethane. The fraction from 
150 ml to 330 ml was collected, concentrated and dried in vacuo to give the pure 
product, succinimidyl 4,4′-azipentanoate 7 (3.9 g, 21% over three steps), as a white 




Compound 10a was synthesized according to the following procedure 
(10b and 10c were synthesized following a similar procedure with minor 
modifications; Supplementary Section 6.3). The SPPS reactor was manually charged 
with Fmoc-Ala-Wang resin 8 (0.5 mmol, 0.476 g). The following steps were 
performed automatically. The resin was swelled in DMF (9 ml) at 25 °C for 1 h. 
Double Fmoc deprotection was performed with piperidine solution in DMF (20% v/v, 
9 ml) for 3 min and 12 min, respectively, at 25 °C. After five washing cycles with 
DMF (9 ml), the amino acid in DMF (4.0 ml, 2.0 mmol, 0.5 M, 4 equiv.) was coupled 
with HBTU in DMF (4.0 ml, 0.46 M, 1.8 mmol, 3.7 equiv.) and 
diisopropylethylamine in N-methyl-2-pyrrolidone (2.0 ml, 2.0 M, 4.0 mmol, 8 equiv.). 
The coupling was performed twice at 25 °C for 1 h (for 10b, coupling was performed 
once for 30 min at 70 °C). The resin was washed five times with DMF (9 ml) after 
each coupling step. After the peptide sequence was assembled, the resin was washed 
five times with DCM (9 ml). At this stage, the diazirine functionalization of the N-
terminus was performed. The solid succinimidyl 4,4′-azipentanoate 7 was dissolved in 
DCM. Then, a solution of diisopropylethylamine in DCM (2 ml, 0.5 M, 1.0 mmol, 2.0 
equiv.) was added to the reactor followed by the solution of 7 in DCM (4 ml, 0.19 M, 
0.75 mmol, 1.5 equiv.). The reaction was stirred at 25 °C for 1 h. Then, the resin was 
washed five times with DCM (9 ml) and dried under a flow of argon for 15 min. The 
cleavage mix (TFA/triisopropylsilane/water, 95/2.5/2.5, v/v/v) was freshly prepared. 
Then, the cleavage mix (10 ml) was added to the resin and stirred at 25 °C for 3 h. 
During this time, diethyl ether (150 ml) was chilled in a separate jacketed filter to 
−25 °C. When the cleavage was complete, the cleavage mix was filtered and the 
filtrate was added to the precooled diethyl ether. The SPPS reactor was rinsed with 
the cleavage mix (3 × 0.5 ml) and the washings were added to the jacketed filter with 
diethyl ether. The crude peptide product 10a was allowed to precipitate for 1 h at 
−25 °C. Then, the precipitate was filtered and the filter cake was washed with diethyl 
ether (4 × 30 ml) at −25 °C. The peptide product was warmed to 25 °C, dissolved in 
acetonitrile (1.5 ml) and water (6.0 ml) and transferred to a tared receiver vial. The 
jacketed filter was washed once with ACN (1.5 ml) and water (6.0 ml), and this liquid 
was added to the receiver vial. The material was further purified manually by 
preparative HPLC to give 10a (21.4 mg, 48.4 µmol, 10% yield, 95% pure) as a white 




All the data are available in the supplementary volume. This includes full 




The code to run the hardware for the automated platforms and the scripts to run the 
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